PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
PRDS
Delisted
PRDS was delisted on the 30th of August, 2023.
61 hedge funds and large institutions have $48.6M invested in Pardes Biosciences, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 21 increasing their positions, 17 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Holders
61
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$1.53M | |
| 2 | +$424K | |
| 3 | +$351K | |
| 4 |
Morgan Stanley
New York
|
+$205K |
| 5 |
MPM
MBB Public Markets
Chicago,
Illinois
|
+$143K |
Top Sellers
| 1 | -$1.8M | |
| 2 | -$1.16M | |
| 3 | -$451K | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$305K |
| 5 |
OMC
Oasis Management Company
Grand Cayman,
Cayman Islands
|
-$296K |